Author:
Hamaoui Karim,Gowers Sally,Boutelle Martyn,Cook Terry H.,Hanna George,Darzi Ara,Smith Richard,Dorling Anthony,Papalois Vassilios
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference45 articles.
1. Taking complement to the clinic—has the time finally come?;Lachmann;Scand J Immunol,2009
2. APT070 (Mirococept), a membrane-localised complement inhibitor, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury;Souza;Br J Pharmacol,2005
3. Attenuation of myocardial reperfusion injury in pigs by Mirococept, a membrane-targeted complement inhibitor derived from human CR1;Banz;Cardiovasc Res,2007
4. APT070 (mirococept), a membrane-localizing C3 convertase inhibitor, attenuates early human islet allograft damage in vitro and in vivo in a humanized mouse model;Xiao;Br J Pharmacol,2016
5. Crosstalk between thrombosis and inflammation in lung reperfusion injury;Farivar;Ann Thorac Surg,2006
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献